Study of the Progression of Chronic Cardiovascular Conditions

Last updated: February 16, 2026
Sponsor: Prolaio
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cardiomyopathy

Chest Pain

Heart Disease

Treatment

N/A

Clinical Study ID

NCT07420907
CTP-030
  • Ages > 18
  • All Genders

Study Summary

This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 18 years of age and older

  • Ability to understand study assessments and give informed consent to data collection

  • Ability to comply with the study protocol

  • Ability to understand and respond to instructions in English

  • Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but notlimited to: HF, AS, HCM, HTN, DCM, etc.

  • Resides in the United States

Exclusion

Exclusion Criteria:

  • Allergy to adhesive used in biosensor patch

  • Life threatening disease process outside of area under study, such as activelytreated cancer or pre/post-transplant such as hepatic failure; end-stage renaldisease.

  • Severe CVD defined by hospital admission for cardiac diagnosis within 30 days ofenrollment or documentation of NYHA functional class IV

  • Self-reported weight of 400 pounds or greater

Study Design

Total Participants: 5000
Study Start date:
October 30, 2025
Estimated Completion Date:
October 31, 2030

Connect with a study center

  • Prolaio

    Chicago 4887398, Illinois 4896861 60606
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.